Hims & Hers Shares In The Spotlight After Launching Multi-Cancer Test

Benzinga_recent_news02-04 23:35

Hims & Hers Health, Inc. (NASDAQ:HIMS) shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test. Hims & Hers said it will offer access to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2608395942?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/04/Hims--Hers.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-02-04 23:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608395942","market":"sh","top_or_hot":-1,"title":"Hims & Hers Shares In The Spotlight After Launching Multi-Cancer Test","media":"Benzinga_recent_news","content":"<div>\n<p>Hims & Hers Health, Inc. (NASDAQ:HIMS) shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test.\nHims & Hers said it will offer access to ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/02/50379055/hims-hers-shares-in-the-spotlight-after-launching-multi-cancer-test\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Shares In The Spotlight After Launching Multi-Cancer Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Shares In The Spotlight After Launching Multi-Cancer Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-04 23:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/02/50379055/hims-hers-shares-in-the-spotlight-after-launching-multi-cancer-test><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hims & Hers Health, Inc. (NASDAQ:HIMS) shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test.\nHims & Hers said it will offer access to ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/02/50379055/hims-hers-shares-in-the-spotlight-after-launching-multi-cancer-test\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMA","symbol_name":"Smartstop Self Storage REIT Inc","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50379055/hims-hers-shares-in-the-spotlight-after-launching-multi-cancer-test","article_id":"2608395942","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/04/Hims--Hers.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50379055/hims-hers-shares-in-the-spotlight-after-launching-multi-cancer-test","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2608395942","pubTimestamp":1770219300,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Hims & Hers Health shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SMA":"Smartstop Self Storage REIT Inc","BK4217":"自存仓储房地产信托"},"translate_title":"Hims&Hers推出多种癌症测试后成为焦点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMA":1},"content_text":"Hims & Hers Health, Inc. (NASDAQ:HIMS) shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test.\nHims & Hers said it will offer access to Galleri, a blood-based multi-cancer early detection test from GRAIL Inc. that screens for signals associated with more than 50 types of cancer, including cancers that do not have recommended routine screenings.\nThe company said the test can be taken annually and is designed to detect cancer signals even before symptoms appear. Galleri's technology also includes a prediction of where in the body the cancer signal may be originating. The company noted the test does not detect all cancers and false positive and false negative results can occur.\nHims & Hers said customers can add the Multi-Cancer Test by Galleri to existing Labs plans starting Wednesday, with a $250 discount to the Galleri list price.\nCEO Andrew Dudum said the launch is intended to expand access to advanced cancer screening technology and help close gaps in access to proactive care. Executives from GRAIL and Hims & Hers said the offering is meant to complement recommended cancer screenings and support earlier detection.\nThe technical indicators paint a more complex picture for Hims & Hers. The stock is currently trading 14.9% below its 20-day simple moving average (SMA) and 37.9% below its 100-day SMA, indicating a bearish trend. Over the past 12 months, shares have decreased by 38.20%, and they are positioned closer to their 52-week lows than highs, reflecting ongoing challenges for the company.\nThe RSI is currently at 29.27, which indicates that the stock is in oversold territory, while the MACD is below its signal line, suggesting bearish pressure. This combination of an oversold RSI and bearish MACD indicates mixed momentum, as the stock struggles to find a clear direction.\nBelow is the Benzinga Edge scorecard for Hims & Hers Health, highlighting its strengths and weaknesses compared to the broader market:\nThe Verdict: Hims & Hers Health’s Benzinga Edge signal reveals a mixed outlook. While the Growth score indicates potential, the weak Value and bearish Momentum scores suggest caution for investors navigating this volatile environment.\nHIMS Price Action: Hims shares traded as high as $27.20 on Wednesday before pulling back. At the time of writing, Hims & Hers stock is trading 0.94% lower at $25.29, according to data from Benzinga Pro.\nImage via Shutterstock\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608395942","isCrawlerRequest":true}